Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evita Solutions is a Danish biotechnology company specializing in advanced cell-based non-invasive prenatal testing (NIPT). The company utilizes a proprietary platform developed by ARCEDI Biotech to isolate rare fetal cells from maternal blood, enabling comprehensive genetic analysis of the fetus without the risks associated with invasive procedures. Unlike standard cfDNA-based NIPT, Evita's technology provides a pure fetal genome, allowing for the detection of a broader range of chromosomal abnormalities and microdeletions. The company is also exploring the application of its cell-isolation technology in the field of oncology for the detection and monitoring of circulating tumor cells (CTCs). Evita Solutions aims to set a new standard in liquid biopsy by providing high-purity cell isolation for comprehensive genetic profiling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evita Solutions.